HOC is our outreach and engagement site which connects us with healthcare professionals, industry personnel and academics worldwide.
Our HOC platform shares blogs from experienced medical writers around the world, bringing you tips on good communication, evaluations of current health economics and outcomes research and healthcare evidence. Mixed in with great information you will find a light-hearted approach to current issues, some valuable downloads, as well as references for further reading.
After selling his travel company – the third largest in the US – to American Express for $6 billion, Hal Rosenbluth could have spent his time fishing, golfing, or globetrotting; instead, he co-founded Take Care Health Systems.
Details
By Duncan Dibble (duncan.dibble@rxcomms.com ) If you Google for ‘website’ and ‘traffic’ you’ll be inundated with miracle cures to increase visitors to your site. It will then take you roughly…
Details
By David Woods ( david.woods@rxcomms.com ) The Association of American Medical Colleges (AAMC) recently issued a 43-page report of its task force on industry funding of medical education. Sections of…
Details
By David Woods (david.woods@rxcomms.com) Journal editors reject submitted manuscripts because they are: Inappropriate for their audience Poorly designed studies Poorly written Seen to have been submitted elsewhere Suspected of conflict…
Details
By Mary Gabb ( mary.gabb@rxcomms.com ) A negative result is defined as one that shows evidence of absent (or no) effect of an intervention; it is not due to absence…
Details
By Ruth Whittington (ruth.whittington@rxcomms.com) With the NHS in the UK nearing its 60th birthday, there’s been considerable talk about whether the system should be put into retirement. At the recent…
Details
By David Woods (david.woods@rxcomms.com) Whether it’s because of a shortage of primary care physicians, impatience at the length of time it takes to see one, or simply increasing costs, the…
Details
By John F P Bridges While outcomes for any given treatment differ significantly among patients, national healthcare systems continue to take a top down population perspective in reviewing not only…
Details
By Mary Gabb (mary.gabb@rxcomms.com) In a previous issue of HOC , we outlined some of the commonly expressed pros and cons of direct-to-consumer advertising (DTCA), which is currently allowed only…
Details
By Julie Stauffer (julie.stauffer@rxcomms.com) Pharmaceutical companies depend on data – and lots of it – to develop drugs and measure their effectiveness. And many patients are eager to supply that…
Details
